European Companies Search Engine

33 EU fundings (€24.9M): EU-Africa Concerted Action on SAR-CoV-2 Virus Variant and Immunological Surveillance … BdlYear 2021 EU Research and Innovation programme "Horizon"

Text

Siren 180036048

01/04/2021 EU funding (€1,541,617): RESilience to Early Developmental Adversity: can children's environment help them overcome the odds?
01/02/2021 EU funding (€1,999,638): BUILDING LINKS BETWEEN EUROPE AND AFRICA IN PERSONALISED MEDICINE
28/01/2021 EU funding (€1,999,720): Optical imaging of retinal function for gene and cell therapies
09/04/2021 EU funding (€1,999,723): Parkinson's disease: does it all start with gut inflammation?
01/11/2021 EU funding (€10M): EU-Africa Concerted Action on SAR-CoV-2 Virus Variant and Immunological Surveillance
04/03/2021 EU funding (€10M): Microglia Control of Physiological Brain States
01/11/2021 EU funding (€15.4M): SARS-coV2 variants Evaluation in pRegnancy and paeDIatrics cohorts
10/03/2021 EU funding (€150,000): A universally applicable system for direct readout of eukaryotic cell transgenesis with a novel integration-coupled gene expression switch
21/05/2021 EU funding (€184,708): Deciphering the dialogue between intestinal macrophages and their tissular niches
01/04/2021 EU funding (€184,708): OsteoCalcin Autophagy to reJuvenate motoneuronAL function
21/05/2021 EU funding (€184,708): Prediction of Children's Math Learning Disability Using Longitudinal Brain Data and Machine Learning
15/04/2021 EU funding (€196,708): Deciphering creativity: A neuro-computational approach to the investigation of creative abilities.
21/05/2021 EU funding (€196,708): MetaCil: Unveiling the molecular interplay between primary cilia and metabolism in cancer
21/05/2021 EU funding (€196,708): Role of perisomatic inhibition on prefrontal cortex neurons in gamma oscillations and cognitive flexibility
26/03/2021 EU funding (€196,708): Sleep microstructure in Parkinson's Disease and REM-sleep Behavior Disorder
01/04/2021 EU funding (€196,708): Targeting dendritic cell plasticity to modulate antigen-specific T cell recall responses in human
09/07/2021 EU funding (€2,000,000): Circuit mechanisms underlying sensory-evoked navigation
11/10/2021 EU funding (€2,125,000): Targeted strategies for prevention and treatment of fibrosis-associated liver cancer
22/01/2021 EU funding (€2,313,809): European Rare dIsease research Coordination and support Action
28/01/2021 EU funding (€22.9M): RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs
28/01/2021 EU funding (€26.5M): VACCELERATE - European Corona Vaccine Trial Accelerator Platform
05/02/2021 EU funding (€3,090,575): Long-range electrodynamic INteractions between proteinS
28/01/2021 EU funding (€3,577,313): Ultrasensitive BIOsensing platform for multiplex CELLular protein PHEnotyping at single-cell level
05/02/2021 EU funding (€3,661,850): Working collaboratively with vulnerable women to identify the best implementation gains by screening cervical cancer more effectively in European countries
05/02/2021 EU funding (€30M): European Clinical Research Alliance on Infectious Diseases
28/05/2021 EU funding (€4,099,075): PI3K/PTEN-related monogenic disease to understand cancer
05/02/2021 EU funding (€4,974,015): Urban Observatory for Multi-participatory Enhancement of Health and Wellbeing
05/02/2021 EU funding (€5,999,571): Innovative tools to study the impact and mode of action of micro and nanoplastics on human health: towards a knowledge base for risk assessment
22/01/2021 EU funding (€6,583,216): Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial
01/01/2021 EU funding (€7,274,776): Network of European funding for neuroscience research - NEURON Cofund2
01/04/2021 EU funding (€9,091,074): Reverse engineering the assembly of the hippocampal scaffold with novel optical and transgenic strategies
19/02/2021 EU funding (€9,992,473): Structure and functions of the brain extracellular space
01/05/2021 EU funding (€9,999,017): Analysis of the T cell’s Tactical Arsenal for Cancer Killing

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Institut National de la Sante et de la Recherche Medicale, Paris, France.